InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
1
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+16.4%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Browse the full record of transactions filed by Car Bruce. Director active across 3 companies, notably AGIOS PHARMACEUTICALS, INC.. Cumulatively, 6 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €938k. Activity tracked since 6 January 2022. The latest transaction was disclosed on 5 January 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Car Bruce
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
6 条申报中的 6 条
About Car Bruce
Car Bruce is a declarant associated with Biohaven Ltd. and Agios Pharmaceuticals, INC., where the listed role is Chief Scientific Officer. Across 6 filings in total, the sampled recent filings run from 2022-01-10 to 2026-01-07 and show purchases totaling EUR 938013, with no sales reported.
